Overview Thiamin Against Robust IBD Fatigue Status: Completed Trial end date: 2020-10-27 Target enrollment: Participant gender: Summary Patients with Inflammatory Bowel Disease (IBD), disease in remission and chronic fatigue will receive oral Thiamine treatment for 4 weeks in a RCT, cross-over study. Phase: Phase 4 Details Lead Sponsor: University of AarhusTreatments: ThiamineVitamin B ComplexVitamins